Nonirritating aqueous ophthalmic compositions comfort formulatio

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514914, 514974, A61K 3152

Patent

active

045593434

ABSTRACT:
Xanthine derivatives are described which decrease the stinging associated with the application of ophthalmic acidic anti-inflammatory agents.

REFERENCES:
patent: 2994640 (1961-08-01), Zellner
patent: 3439094 (1969-04-01), Emele
patent: 3632742 (1972-01-01), Eckert et al.
patent: 3957994 (1976-05-01), Schroer
patent: 4141976 (1979-02-01), Voorhees
patent: 4420483 (1983-12-01), Sunshine et al.
J. Pharm. Exp. Thera. 198(2) 481-488 (1976)--Bito et al.
Chem. Abst. 77, 9594(u) (1972)--Riviere.
Chem. Abst. 84, 130,369(x) (1976)--Bourillet et al.
Chem. Abst. 95, 18119(s) (1981)--Fujimura et al.
Abstract B-5 ReBE-897, 356-A and 22.07.82 US 400, 597.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nonirritating aqueous ophthalmic compositions comfort formulatio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nonirritating aqueous ophthalmic compositions comfort formulatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonirritating aqueous ophthalmic compositions comfort formulatio will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2175190

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.